Aaron Weitzman

60% of Americans under 65 got health insurance through their employer in 2023.

Given its size and based on initial market feedback, ABM is a likely bolt-on candidate.

Dealmakers anticipate a return to a more traditional health care antitrust environment post-election.

Patients receiving an opioid prescription have a 44% increased risk of long-term use.

Demand for remote patient monitoring is skyrocketing as the prevalence of chronic conditions like diabetes grows.

R&D costs for a new drug range from $314 million to $4.46 billion.

Drug distributors have emerged as reliable buyers for private equity's physician businesses

Grant Avenue Capital invested $55 million

From 2020 to 2030, 15 million more people will age into Medicare, many of whom will need home care and services

Former President Trump's return